MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$28,232K
(8.38%↑ Y/Y)
Net loss
-$27,937K
(9.94%↑ Y/Y)
Total other
comprehensive (loss) income
-$295K
(-241.83%↓ Y/Y)
Interest income
$1,912K
(-41.90%↓ Y/Y)
Other income
$435K
(4.07%↑ Y/Y)
Loss before income
taxes
-$27,923K
(9.88%↑ Y/Y)
Income tax provision
$14K
(-62.16%↓ Y/Y)
Net unrealized
(loss) gain on...
-$295K
(-241.83%↓ Y/Y)
Total other income,
net
$2,347K
(-36.72%↓ Y/Y)
Operating loss
-$30,270K
(12.75%↑ Y/Y)
Collaboration revenue
$2,593K
(-59.94%↓ Y/Y)
Total operating
expenses
$32,863K
(-20.17%↓ Y/Y)
Research and development
$24,602K
(-21.96%↓ Y/Y)
General and
administrative
$8,261K
(-14.30%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Voyager Therapeutics, Inc. (VYGR)
Voyager Therapeutics, Inc. (VYGR)